|
Test Catalog
|
|
BAbScreen™/NAbFeron® Antibody Test |
#194 |
|
| Type of Disorder: |
Multiple Sclerosis |
|
| Typical Presentation: |
Multiple Sclerosis |
|
| Indications for Testing: |
Individuals on Interferon?-1 therapy, both 1a and 1b |
|
| Disease(s) tested for: |
Multiple sclerosis |
|
| Test Details |
|
| Test Code: |
194 |
|
| Informed Consent Required: |
No |
|
| Medicare ABN Required: |
No |
|
| Special Notes: |
Sample needs to be collected either before treatment with interferon or more than 24 hours following the most recent dose. Patient should not be on steroid therapy for at least two weeks prior to testing. |
|
| Technical Information |
|
| Utility: |
Detection of binding and neutralizing
antibodies to interferon?-1 |
|
| Methodology: |
Viral cytopathic effect assay |
|
| Reference Value: |
For NAbs; Normal titer: >20
Mild/Moderate titer: 21-60
High titer >60 |
|
| CPT Code(s): |
83520(1), 86382(1), 87253(1), 83912(1) |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Serum |
| Minimum Volume: |
2ml |
| Collection Tube: |
Red top |
|
| Alternate
Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
10ml |
| Collection Tube: |
Red top |
|
| Storage Conditions: |
Refrigerate |
|
| Shipping Conditions: |
Room temperature, avoid freezing. Ship within 24 hours of drawing. |
|
| Test Turnaround: |
14-21 days |
|
|
|
